.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Army
Federal Trade Commission
Farmers Insurance
Express Scripts
AstraZeneca
Covington
Harvard Business School
Chubb
Cerilliant

Generated: November 20, 2017

DrugPatentWatch Database Preview

VINCRISTINE SULFATE PFS Drug Profile

« Back to Dashboard

What is the patent landscape for Vincristine Sulfate Pfs, and what generic Vincristine Sulfate Pfs alternatives are available?

Vincristine Sulfate Pfs is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs.

The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.

Pharmacology for VINCRISTINE SULFATE PFS

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid

Medical Subject Heading (MeSH) Categories for VINCRISTINE SULFATE PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
VINCRISTINE SULFATE PFS
vincristine sulfate
INJECTABLE;INJECTION071484-001Apr 19, 1988APRXNoYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
VINCRISTINE SULFATE PFS
vincristine sulfate
INJECTABLE;INJECTION075493-001Sep 1, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Cipla
Julphar
Farmers Insurance
QuintilesIMS
Baxter
Argus Health
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot